V2 Clinical Infrastructure

V2 is passive clinical infrastructure designed to reduce error without changing how clinicians work.

The system operates in the background, correcting administrative and billing inaccuracies in real time while preserving existing workflows.

Cancer Immunotherapy Development

Manna Corp operates an independent cancer immunotherapy development program.

A lead immunotherapy candidate is advancing under a defined regulatory pathway.

Development is guided by validated mechanism data and aligned with FDA expectations for clinical translation.